Anaesthesia for Hip and Knee Arthroplasty (SPIGA) (SPIGA)

September 24, 2026 updated by: Ole Mathiesen, Zealand University Hospital

Spinal Versus General Anaesthesia for Hip and Knee Arthroplasty. The Randomised, Clinical, Multicentre SPIGA Trial

Beneficial and harmful effects of spinal versus general anaesthesia in patients undergoing hip and knee arthroplasty.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

Effective and safe anaesthesia is fundamental to perioperative care. Hip and knee arthroplasty are among the most frequently performed surgical procedures worldwide and are typically performed under either spinal or general anaesthesia. However, high-quality comparative evidence regarding the benefits and harms of these anaesthetic techniques remains limited and inconclusive.

Both techniques are associated with short- and long-term risks, including postoperative nausea and vomiting, hypotension, nerve injury, acute kidney injury, and respiratory and cardiovascular complications. In addition, they may differentially modulate the surgical stress response, potentially influencing postoperative recovery and risk of complications.

Objective:

To compare the benefits and harms of spinal versus general anaesthesia in patients undergoing hip or knee replacement. We hypothesise that spinal anaesthesia results in better postoperative outcomes than general anaesthesia.

Intervention:

Patients undergoing elective primary hip or knee arthroplasty will be randomised to receive either spinal or general anaesthesia, with randomisation stratified by participating centre.

Design:

The SPIGA trial is an investigator-initiated, multicentre, randomised, superiority clinical trial. Participants will be randomly allocated at a 1:1 ratio using a central, computer-generated randomisation sequence. A total sample size of 3000 participants was determined using simulation-based methods to provide at least 90% power to detect a prespecified minimally clinically important difference, corresponding to an increase of one hospital-free day in at least 10% of participants at a two-sided significance level of 0.05.

Planned sub-studies

  • Short-term perioperative outcomes (0-24h postoperatively)
  • Stratified analysis of anaesthetic regimens
  • Impact of preoperative clinical frailty

Study Type

Interventional

Enrollment (Estimated)

3000

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Scheduled for elective primary elective hip or knee arthroplasty, including unicompartmental knee

Exclusion Criteria:

  • Scheduled for elective primary hip or knee arthroplasty, including unicompartmental knee
  • Age ≥ 18 years
  • Unable to communicate in written and/or spoken Danish Contraindications against either spinal or general anaesthesia

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Spinal Anaesthesia

Spinal anaesthesia according to local practice, including optional sedation with sedative-hypnotic pharmacological agents

Active Comparator: General Anaesthesia

General anaesthesia according to local practice

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hospital-free days within 30 days
Time Frame: Postoperative day 0-30

Defined as the number of days within the first 30 days following hip or knee arthroplasty surgery during which a participant is alive and not admitted to a hospital.

Postoperative day 0-30

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Major complications
Time Frame: Postoperative day 0-30

A major complication is defined as a major intra- or postoperative adverse event occurring from the initiation of anaesthesia through 30 days postoperatively.

Postoperative day 0-30
Quality of Recovery
Time Frame: 24 hours postoperatively

The Quality of Recovery-15 questionnaire (QoR-15) generates a composite score ranging from 0 to 150 across five domains (physical comfort, emotional state, physical independence, psychological support, and pain), with higher scores indicating better recovery.

24 hours postoperatively

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient satisfaction with anaesthesia
Time Frame: 24 hours postoperatively

Assessed 24 hours postoperatively by asking patients to rate their satisfaction on a numeric rating scale (NRS) from 0-10, where 0 indicates not satisfied at all/completely dissatisfied and 10 indicates extremely satisfied/fully satisfied.

24 hours postoperatively
Health-related quality of life (EQ5D5L-VAS)
Time Frame: Postoperative day 30

Evaluation of health-related quality of life using the EuroQol EQ5D5L- VAS questionnaire that adresses mobility, self-care, usual activities, pain/discomfort, anxiety/depression. The VAS is a vertical visual analogue score of self-rated health (EQ-VAS, 0 = "The worst health you can imagine" and 100 = "The best health you can imagine").

Postoperative day 30
Number of unplanned hospital-visits
Time Frame: Postoperative day 0-30

Defined as the number of any unplanned contact with the emergency department, outpatient clinic, or other hospital department.

Postoperative day 0-30
Willingness to repeat the type of anaesthesia
Time Frame: 24 hours postoperatively

Assessed at 24 hours postoperatively by asking participants whether they would choose the same type of anaesthesia again in case of future surgery.

24 hours postoperatively
Day-case discharge
Time Frame: Postoperative day 0

Number of patients assessed as eligible for day-case surgery being discharged on the day of surgery.

Postoperative day 0

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

October 1, 2026

Primary Completion (Estimated)

September 1, 2031

Study Completion (Estimated)

September 1, 2031

Study Registration Dates

First Submitted

September 7, 2026

First Submitted That Met QC Criteria

September 15, 2026

First Posted (Actual)

September 22, 2026

Study Record Updates

Last Update Posted (Actual)

September 29, 2026

Last Update Submitted That Met QC Criteria

September 24, 2026

Last Verified

August 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • EMN-2026-05830

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Data will be published anonymised in accordance with ICMJE (International Committee of Medical Journal Editors) guidelines.

IPD Sharing Time Frame

The study protocol and statistical analysis plan will be available after they have been published.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.